Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Winn

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|March 10, 2011
Neuromuscular blockade resistance during therapeutic hypothermiaScott W Mueller, Robert Winn, Madison Macht, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Lung Cancer Prevalence in Virginia: A Spatial Zipcode-Level Analysis via INLAIndranil Sahoo, Jinlei Zhao, Xiaoyan Deng, et al.
Oncogene|December 21, 2004
Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)Yvette Bren-Mattison, Vicki Van Putten, Daniel Chan, et al.
ANZ Journal of Surgery|July 31, 2020
Factors influencing recurrence of stage I-III rectal cancer in regional AustraliaLucy Haggstrom, Sharlyn Kang, Robert Winn, et al.
Journal of Gastrointestinal Oncology|September 21, 2020
High body mass index is associated with an increased overall survival in rectal cancerKarolina Juszczyk, Sharlyn Kang, Soni Putnis, et al.
ANZ Journal of Surgery|April 7, 2021
Survival in stage IIB/C compared to stage IIIA rectal cancer: an Australian experience affirming that size does matterMarie Shella De Robles, Robert S O'Neill, Ali P Mourad, et al.
Plos One|February 18, 2010
Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injuryAkiko Iwata, Vicki Morgan-Stevenson, Barbara Schwartz, et al.
Clinical Breast Cancer|September 22, 2024
Trust in Black and White Breast Cancer Patients: Opportunities to Enhance Trustworthiness in Cancer CareVanessa B Sheppard, Fariha Tariq, Dustin Bastiach, et al.
American Journal of Human Genetics|April 20, 2024
Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgroundsYing Wang, Yixuan He, Yue Shi, et al.
JAMA Oncology|August 4, 2018
Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening TrialMary M Pasquinelli, Kevin L Kovitz, Matthew Koshy, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|March 10, 2011
Neuromuscular blockade resistance during therapeutic hypothermiaScott W Mueller, Robert Winn, Madison Macht, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Lung Cancer Prevalence in Virginia: A Spatial Zipcode-Level Analysis via INLAIndranil Sahoo, Jinlei Zhao, Xiaoyan Deng, et al.
Oncogene|December 21, 2004
Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)Yvette Bren-Mattison, Vicki Van Putten, Daniel Chan, et al.
ANZ Journal of Surgery|July 31, 2020
Factors influencing recurrence of stage I-III rectal cancer in regional AustraliaLucy Haggstrom, Sharlyn Kang, Robert Winn, et al.
Journal of Gastrointestinal Oncology|September 21, 2020
High body mass index is associated with an increased overall survival in rectal cancerKarolina Juszczyk, Sharlyn Kang, Soni Putnis, et al.
ANZ Journal of Surgery|April 7, 2021
Survival in stage IIB/C compared to stage IIIA rectal cancer: an Australian experience affirming that size does matterMarie Shella De Robles, Robert S O'Neill, Ali P Mourad, et al.
Plos One|February 18, 2010
Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injuryAkiko Iwata, Vicki Morgan-Stevenson, Barbara Schwartz, et al.
Clinical Breast Cancer|September 22, 2024
Trust in Black and White Breast Cancer Patients: Opportunities to Enhance Trustworthiness in Cancer CareVanessa B Sheppard, Fariha Tariq, Dustin Bastiach, et al.
American Journal of Human Genetics|April 20, 2024
Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgroundsYing Wang, Yixuan He, Yue Shi, et al.
JAMA Oncology|August 4, 2018
Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening TrialMary M Pasquinelli, Kevin L Kovitz, Matthew Koshy, et al.
Pageof 6